X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Counterfeit pills on social media are a stark reminder of how importation schemes could further threaten patient lives

By Gabby Migliara  |    July 6, 2022
Last month, as part of efforts to advance legislation reauthorizing the critical U.S. Food and Drug Administration (FDA) user fee agreements, the Senate HELP Committee included a dangerous proposal...   Read More

Why drug importation is bad for Americans

By Gabby Migliara  |    May 12, 2022
Drug importation schemes are dangerous and have significant negative consequences for both individuals and our health care system. Importation refers to when governments or individuals circumvent the...   Read More

PhRMA submits comments on FDA’s proposed rule on drug importation

By Nicole Longo  |    March 10, 2020
Yesterday, PhRMA submitted comments in response to the Food and Drug Administration’s proposed rule, “Importation of Prescription Drugs.” As PhRMA President and CEO Stephen J. Ubl stated when the...   Read More

Drug importation: An old idea that is still a bad idea

By Nicole Longo  |    January 28, 2020
2020 may have kicked off a new decade, but policymakers are stuck in the past, focusing on old, dangerous ideas like drug importation. For all the same reasons we’ve discussed before, drug...   Read More

What they’re saying: Safety is top concern for recent drug importation proposal

By Nicole Longo  |    August 8, 2019
Last week, the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) released their “Safe Importation Action Plan,” which would allow importation of...   Read More

ICYMI: Canadian government, stakeholders voice concerns with drug importation proposals

By Tiffany Haverly  |    August 1, 2019
This week, the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration announced their “Safe Importation Action Plan.” While patients are rightfully concerned about the...   Read More

PhRMA responds to Florida’s request for information on drug importation

By Tiffany Haverly  |    June 26, 2019
PhRMA remains committed to working with lawmakers to ensure patients can afford and access their medicines, but importation schemes that put patient safety at risk will never be the right approach.   Read More

PhRMA CEO raises concerns with Florida importation proposal, highlights reforms needed to lower costs for patients

By Tiffany Haverly  |    May 8, 2019
PhRMA is committed to working with lawmakers to ensure patients can access and afford their medicines, but importation schemes that put patient safety at risk are the wrong approach. In a recent...   Read More

Resources for understanding the dangers of drug importation

By Nicole Longo  |    March 28, 2017
Recent proposals to allow drug importation from other countries are dangerous for patients and the U.S. drug supply chain. To better understand how these importation schemes could negatively affect...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."